Please login to the form below

Blopress

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Blopress was produced by Takeda.

Takeda CEO admits to Blopress mis-marketing

Hasegawa told the Wall Street Journal that the company had used a graph in promotional literature indicating Blopress (candesartan cilexetil) was more effective than rival blood pressure drug Norvasc (amlodipine) from ... Blopress - also sold as Atacand -

Takeda rides out Actos decline as fiscal 2012 sales rise

steep decline for antihypertensive Blopress (candesartan), also on generic competition, which ended the year down 22 per cent to 169bn yen. ... The drug's US launch is due in the summer. Azilva also contributed to Takeda's domestic sales growth on the

Country report: The healthcare market in Japan

Aricept. donepezil. Eisai. Alzheimer's disease. 2. Blopress. candesartan. Takeda. Hypertension. 3.

EU approval for Takeda's once-daily hypertension drug Edarbi

Takeda's own candesartan cilexetil (marketed as Amias and Blopress in Europe), which made $2.8bn last year.

A rush for sweet success

DysportTM (Medicis). Glabellar lines. US. Candesartan cilexetil/hydrochlorothiazide. Blopress Plus (Takeda). Essential hypertension.

1 2 3 [ Next 5 results ]

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Senior / Principal Medical Writer - MedComms - Home Based / Vari...: Excellent Remuneration Packages

Hybrid Role - Principal Medical Writer / Account Handler - Publi...: Salary TBC

Senior Account Director/ Associate Director- Pharma and Life Sci...: Competitive salary and benefits

Project Manager - Medical Communications – South Wales: Excellent Remuneration Package

Senior Account Manager- Pharma and Life Scienes: Competitive salary and benefits

Editorial / Copy Lead – Healthcare Advertising – Central London...: Salary TBC

Director – Healthcare PR: Salary TBC

Account Manager / Senior Account Manager - Healthcare Advertisin...: Excellent Remuneration

PR Associate Director – Consumer Health & Beauty: Salary TBC

Project Manager - Digital Healthcare - London: Excellent Remuneration Package

Freelance Medical Writer - Healthcare Advertising - London: Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day

Editorial/ Medical Director – Med Ed & Comms – Home-based...: Salary TBC

Home-based Principal Medical Writer – Medical Comms: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Senior Medical Writer: Competitive salary and benefits

Editor – Medical Education Agency – Bucks: Salary TBC

Account Director, Medical Education: Salary TBC

Experienced / Senior Account Director - Publications - London: Up to £80, 000 plus great benefits

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior Medical Writer: Salary TBC

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality: How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA: Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad: Six behaviours separate the good brand teams from the bad...